Found 38 matching trials
Psilocybin for Treatment-Resistant Depression
PHASE2The purpose of this study is to see if psilocybin, an investigational drug,...
Location
Canadian Rapid Treatment Centre of Excellence (CRTCE)
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
PHASE2This pilot clinical trial will study psilocybin-assisted therapy for adults...
Location
Arthur Child Comprehensive Cancer Centre
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
PHASE1This randomised controlled feasibility trial evaluates the Digital Interven...
Location
University College London
Psilocybin for Major Depressive Disorder (MDD)
PHASE3Approximately 240 eligible adult participants (β₯18 years old) who meet Diag...
Status
Active Not Recruiting
Location
University of Alabama Clinical Research Unit
Pragmatic Trial of Psilocybin Therapy in Palliative Care
PHASE2This multicenter, triple-blind, phase 2, randomized controlled trial will e...
Location
Marin Cancer Care
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin
PHASE2The purpose of this study is to see if one or two doses of psilocybin is mo...
Status
Active Not Recruiting
Location
Toronto Western Hospital
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
PHASE1The goal of this clinical trial is to systematically categorize potential p...
Location
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General Psychiatry
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
PHASE1This study is an open-label, single-arm, proof-of-concept study, wherein tr...
Status
Active Not Recruiting
Location
Toronto Western Hospital - University Health Network
Mindfulness-Assisted Psychedelic Therapy
PHASE2The goal of this clinical trial is to test psilocybin in combination with m...
Location
Univeristy of Southern California Brain and Creativity Institute
A Study of Psilocybin for Major Depressive Disorder (MDD)
PHASE2One hundred participants, ages 21 to 65, who meet Diagnostic and Statistica...
Location
University of California, San Francisco